<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">oncotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский онкологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian journal of oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-4861</issn><issn pub-type="epub">2312-3168</issn><publisher><publisher-name>Tomsk National Research Medical Сепtеr of the Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21294/1814-4861-2025-24-4-162-169</article-id><article-id custom-type="elpub" pub-id-type="custom">oncotomsk-3785</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЛУЧАЙ ИЗ КЛИНИЧЕСКОЙ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Особенности и подходы к лечению пациентов с сочетанием рака легкого и лимфопролиферативных заболеваний</article-title><trans-title-group xml:lang="en"><trans-title>Features and approaches to treating patients with concurrent lung cancer and lymphoproliferative disorders</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-3674-876X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Перминов</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Perminov</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Перминов Юрий Викторович, онколог, торакальный хирург </p><p>191036, г. Санкт-Петербург, Лиговский пр., 2–4 </p></bio><bio xml:lang="en"><p>Yuriy V. Perminov, MD, Oncologist, Thoracic Surgeon </p><p>2–4, Ligovsky ave., Saint Petersburg, 191036 </p></bio><email xlink:type="simple">iuriiperminov88@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6228-182X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нефедов</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Nefedov</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нефедов Андрей Олегович, кандидат медицинских наук, старший научный сотрудник, заведующий отделением торакальной онкологии </p><p>191036, г. Санкт-Петербург, Лиговский пр., 2–4 </p></bio><bio xml:lang="en"><p>Andrei O. Nefedov, MD, PhD, Senior Researcher, Head of the Department of Thoracic Oncology </p><p>2–4, Ligovsky ave., Saint Petersburg, 191036 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5838-6861</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мортада</surname><given-names>М.М.</given-names></name><name name-style="western" xml:lang="en"><surname>Mortada</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мортада Махмуд Мустафа, онколог, торакальный хирург </p><p>191036, г. Санкт-Петербург, Лиговский пр., 2–4 </p></bio><bio xml:lang="en"><p>Makhmud M. Mortada, MD, Oncologist, Thoracic Surgeon </p><p>2–4, Ligovsky ave., Saint Petersburg, 191036 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2810-8852</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудряшов</surname><given-names>Г. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudryashov</surname><given-names>G. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кудряшов Григорий Геннадиевич, кандидат медицинских наук, ведущий научный сотрудник, руководитель отдела пульмонологии и центра торакальной хирургии, торакальный хирург высшей категории</p><p>191036, г. Санкт-Петербург, Лиговский пр., 2–4 </p></bio><bio xml:lang="en"><p>Grigoriy G. Kudryashov, MD, PhD, Leading Researcher, Head of the Department of Pulmonology and Thoracic Surgery Center, Thoracic Surgeon of the highest category</p><p>2–4, Ligovsky ave., Saint Petersburg, 191036 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-6485-1169</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кызылова</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kyzylova</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кызылова Екатерина Михайловна, онколог, торакальный хирург; ассистент кафедры госпитальной хирургии медицинского факультета </p><p>191036, г. Санкт-Петербург, Лиговский пр., 2–4 </p></bio><bio xml:lang="en"><p>Ekaterina M. Kyzylova, MD, Oncologist, Thoracic Surgeon; Assistant Professor, Department of Hospital Surgery, Faculty of Medicine </p><p>2–4, Ligovsky ave., Saint Petersburg, 191036 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8437-4891</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ходырева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khodyreva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ходырева Ольга Валерьевна, патологоанатом отделения патологической анатомии </p><p>191036, г. Санкт-Петербург, Лиговский пр., 2–4 </p></bio><bio xml:lang="en"><p>Olga V. Khodyreva, MD, Anatomic Pathologist of the first category, Department of Pathological Anatomy </p><p>2–4, Ligovsky ave., Saint Petersburg, 191036 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4385-9643</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яблонский</surname><given-names>П. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Yablonskiy</surname><given-names>P. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яблонский Петр Казимирович, доктор медицинских наук, профессор; проректор, профессор кафедры госпитальной хирургии медицинского факультета </p><p>191036, г. Санкт-Петербург, Лиговский пр., 2–4 </p><p>199034, г. Санкт-Петербург, Университетская наб., 7–9 </p></bio><bio xml:lang="en"><p>Petr K. Yablonskiy, MD, DSc, Professor; Vice-Rector, Professor, Department of Hospital Surgery, Faculty of Medicine </p><p>2–4, Ligovsky ave., Saint Petersburg, 191036 </p><p>7–9, Universitetskaya emb., Saint Petersburg, 199034 </p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint Petersburg State Research Institute of Phthisiopulmonology, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии» Минздрава России ; ФГБОУ ВПО «Санкт-Петербургский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint Petersburg State Research Institute of Phthisiopulmonology, Ministry of Health of Russia ; Saint Petersburg State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>01</day><month>10</month><year>2025</year></pub-date><volume>24</volume><issue>4</issue><fpage>162</fpage><lpage>169</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Перминов Ю.В., Нефедов А.О., Мортада М.M., Кудряшов Г.Г., Кызылова Е.М., Ходырева О.В., Яблонский П.К., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Перминов Ю.В., Нефедов А.О., Мортада М., Кудряшов Г.Г., Кызылова Е.М., Ходырева О.В., Яблонский П.К.</copyright-holder><copyright-holder xml:lang="en">Perminov Y.V., Nefedov A.O., Mortada M.M., Kudryashov G.G., Kyzylova E.M., Khodyreva O.V., Yablonskiy P.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.siboncoj.ru/jour/article/view/3785">https://www.siboncoj.ru/jour/article/view/3785</self-uri><abstract><p>Актуальность. По данным эпидемиологических исследований, доля первично-множественных злокачественных новообразований составляет от 2 до 17 %. Сочетание рака легкого и лимфомы встречается до 15 % случаев среди всех сочетаний лимфопролиферативных заболеваний со злокачественными новообразованиями других органов. Общепринятой тактики диагностики и лечения данной группы пациентов на данный момент не существует. Цель исследования – представить серию клинических случаев, показывающих значимость персонифицированного подхода в диагностике и лечении пациентов с сочетанием рака легкого и лимфопролиферативных заболеваний. Описание клинических случаев. Представлены два клинических случая синхронного выявления рака легкого и В-клеточной лимфомы. В обоих случаях при обследовании установлен диагноз первично-множественных злокачественных новообразований, что позволило определить оптимальную тактику лечения. Заключение. Рак легкого необходимо включать в дифференциальный диагноз при легочном поражении у больных хроническим лейкозом или лимфомой. Тщательное обследование и морфологическая верификация выявленных изменений у данной группы пациентов помогут определить правильную тактику лечения.</p></abstract><trans-abstract xml:lang="en"><p>Background. Epidemiological studies show that the incidence of synchronous multiple primary malignant neoplasms ranges from 2 % to 17 %. the co-occurrence of lung cancer and lymphoma accounts for 15 % of all combinations of lymphoproliferative diseases with malignant neoplasms of other organs. Currently, there is no universally accepted diagnostic and treatment strategy for this patient group. Objective: To present a series of clinical cases demonstrating the significance of a personalized approach in the diagnosis and treatment of patients with the concurrent diagnosis of lung cancer and lymphoproliferative diseases. Case reports. We report two cases of synchronous lung cancer and B-cell lymphoma. In both cases, diagnosis of multiple primary malignancies guided optimal treatment strategies. Conclusion. Lung cancer should be included in the differential diagnosis of pulmonary lesions in patients with chronic leukemia or lymphoma. a thorough examination and morphological verification of the identified changes in this group of patients will help to choose the correct treatment strategy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак легкого</kwd><kwd>лимфома</kwd><kwd>лимфопролиферативные заболевания</kwd><kwd>первично-множественные злокачественные опухоли</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lung cancer</kwd><kwd>lymphoma</kwd><kwd>lymphoproliferative diseases</kwd><kwd>primary multiple malignant tumors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Vogt A., Schmid S., Heinimann K., Frick H., Herrmann C., Cerny T., Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017; 2(2): e000172. doi: 10.1136/esmoopen-2017-000172.</mixed-citation><mixed-citation xml:lang="en">Vogt A., Schmid S., Heinimann K., Frick H., Herrmann C., Cerny T., Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017; 2(2): e000172. doi: 10.1136/esmoopen-2017-000172.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Altekruse S.F., Kosary C.L., Krapcho M., Neyman N., Aminou R., Waldron W., Ruhl J., Howlader N., Tatalovich Z., Cho H., Mariotto A., Eisner M.P., Lewis D.R., Cronin K., Chen H.S., Feuer E.J., Stinchcomb D.G., Edwards B.K. (eds). SEER Cancer Statistics Review, 1975-2007. National Cancer Institute. Bethesda, MD. URL: https://seer.cancer.gov/csr/1975_2007/, based on Nov. 2009 SEER data submission, posted to the SEER web site, 2010. [Internet]. [cited 01.03.2025].</mixed-citation><mixed-citation xml:lang="en">Altekruse S.F., Kosary C.L., Krapcho M., Neyman N., Aminou R., Waldron W., Ruhl J., Howlader N., Tatalovich Z., Cho H., Mariotto A., Eisner M.P., Lewis D.R., Cronin K., Chen H.S., Feuer E.J., Stinchcomb D.G., Edwards B.K. (eds). SEER Cancer Statistics Review, 1975-2007. National Cancer Institute. Bethesda, MD. URL: https://seer.cancer.gov/csr/1975_2007/, based on Nov. 2009 SEER data submission, posted to the SEER web site, 2010. [Internet]. [cited 01.03.2025].</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Xu F., Liang Y., Mo W.B., Yan X.J., Zhang R. Concurrent lung adenocarcinoma and bladder diffuse large B-cell lymphoma: a case report and literature review. J Int Med Res. 2022; 50(2): 3000605221081672. doi: 10.1177/03000605221081672.</mixed-citation><mixed-citation xml:lang="en">Xu F., Liang Y., Mo W.B., Yan X.J., Zhang R. Concurrent lung adenocarcinoma and bladder diffuse large B-cell lymphoma: a case report and literature review. J Int Med Res. 2022; 50(2): 3000605221081672. doi: 10.1177/03000605221081672.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chinen Y., Tanba K., Takagi R., Uchiyama H., Uoshima N., Shimura K., Fuchida S.I., Kiyota M., Nakao M., Tsukamoto T., Shimura Y., Kobayashi T., Horiike S., Wada K., Shimazaki C., Kaneko H., Kobayashi Y., Taniwaki M., Yokota I., Kuroda J.; Kyoto Clinical Hematology Study Group investigators. Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma. Leuk Lymphoma. 2020; 61(14): 3378–86. doi: 10.1080/10428194.2020.1811862.</mixed-citation><mixed-citation xml:lang="en">Chinen Y., Tanba K., Takagi R., Uchiyama H., Uoshima N., Shimura K., Fuchida S.I., Kiyota M., Nakao M., Tsukamoto T., Shimura Y., Kobayashi T., Horiike S., Wada K., Shimazaki C., Kaneko H., Kobayashi Y., Taniwaki M., Yokota I., Kuroda J.; Kyoto Clinical Hematology Study Group investigators. Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma. Leuk Lymphoma. 2020; 61(14): 3378–86. doi: 10.1080/10428194.2020.1811862.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Yamada T., Shinohara K., Takeda K., Kameda N., Katsuki K., Ariyoshi K., Kamei T. Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin’s lymphoma. Jpn J Clin Oncol. 1999; 29(4): 226–28. doi: 10.1093/jjco/29.4.226.</mixed-citation><mixed-citation xml:lang="en">Yamada T., Shinohara K., Takeda K., Kameda N., Katsuki K., Ariyoshi K., Kamei T. Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin’s lymphoma. Jpn J Clin Oncol. 1999; 29(4): 226–28. doi: 10.1093/jjco/29.4.226.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Konits P.H., Aisner J., Whitacre M., Wiernik P.H. Lung cancer as a complication of prolonged survival in patients with lymphoma. Med Pediatr Oncol. 1982; 10(4): 331–38. doi: 10.1002/mpo.2950100403.</mixed-citation><mixed-citation xml:lang="en">Konits P.H., Aisner J., Whitacre M., Wiernik P.H. Lung cancer as a complication of prolonged survival in patients with lymphoma. Med Pediatr Oncol. 1982; 10(4): 331–38. doi: 10.1002/mpo.2950100403.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">List A.F., Doll D.C., Greco F.A. Lung cancer in Hodgkin’s disease: association with previous radiotherapy. J Clin Oncol. 1985; 3(2): 215–21. doi: 10.1200/JCO.1985.3.2.215.</mixed-citation><mixed-citation xml:lang="en">List A.F., Doll D.C., Greco F.A. Lung cancer in Hodgkin’s disease: association with previous radiotherapy. J Clin Oncol. 1985; 3(2): 215–21. doi: 10.1200/JCO.1985.3.2.215.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">van Leeuwen F.E., Somers R., Taal B.G., van Heerde P., Coster B., Dozeman T., Huisman S.J., Hart A.A. Increased risk of lung cancer, nonHodgkin’s lymphoma, and leukemia following Hodgkin’s disease. J Clin Oncol. 1989; 7(8): 1046–58. doi: 10.1200/JCO.1989.7.8.1046.</mixed-citation><mixed-citation xml:lang="en">van Leeuwen F.E., Somers R., Taal B.G., van Heerde P., Coster B., Dozeman T., Huisman S.J., Hart A.A. Increased risk of lung cancer, nonHodgkin’s lymphoma, and leukemia following Hodgkin’s disease. J Clin Oncol. 1989; 7(8): 1046–58. doi: 10.1200/JCO.1989.7.8.1046.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fukaura A., Tazawa H., Fujii H., Nakatani K., Katsura T., Mochizuki T., Mizuno M., Takahashi T., Tsuruoka N. Synchronous cancer of squamous cell carcinoma of the lung and lymphocytic leukemia (B-cell type): a case report. Jpn J Clin Oncol. 1992; 22(3): 210–15.</mixed-citation><mixed-citation xml:lang="en">Fukaura A., Tazawa H., Fujii H., Nakatani K., Katsura T., Mochizuki T., Mizuno M., Takahashi T., Tsuruoka N. Synchronous cancer of squamous cell carcinoma of the lung and lymphocytic leukemia (B-cell type): a case report. Jpn J Clin Oncol. 1992; 22(3): 210–15.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Graziano F., Cellerino R., Menestrina F., Nicoli N., Gramazio A., Latini L., Piga A. Synchronous primary hepatic lymphoma and epidermoid lung carcinoma treated with chemotherapy and surgery. Am J Clin Oncol. 1995; 18(3):194–98. doi: 10.1097/00000421-199506000-00003.</mixed-citation><mixed-citation xml:lang="en">Graziano F., Cellerino R., Menestrina F., Nicoli N., Gramazio A., Latini L., Piga A. Synchronous primary hepatic lymphoma and epidermoid lung carcinoma treated with chemotherapy and surgery. Am J Clin Oncol. 1995; 18(3):194–98. doi: 10.1097/00000421-199506000-00003.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Koschmieder S., Fauth F., Kriener S., Hoelzer D., Seipelt G. Effective treatment of simultaneous small cell lung cancer and B-cell lymphoma. Leuk Lymphoma. 2002; 43(3): 645–47. doi: 10.1080/10428190290012209.</mixed-citation><mixed-citation xml:lang="en">Koschmieder S., Fauth F., Kriener S., Hoelzer D., Seipelt G. Effective treatment of simultaneous small cell lung cancer and B-cell lymphoma. Leuk Lymphoma. 2002; 43(3): 645–47. doi: 10.1080/10428190290012209.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fonseca D., Musthyala B., Ahmed F., Murthy S.S., Raju K.V. A tale of synchronous lung carcinoma and diffuse large B-cell lymphoma of ileum: A rare combination. Lung India. 2015; 32(4): 398–401. doi: 10.4103/0970-2113.159598.</mixed-citation><mixed-citation xml:lang="en">Fonseca D., Musthyala B., Ahmed F., Murthy S.S., Raju K.V. A tale of synchronous lung carcinoma and diffuse large B-cell lymphoma of ileum: A rare combination. Lung India. 2015; 32(4): 398–401. doi: 10.4103/0970-2113.159598.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yohannan B., Sridhar A., Kachira J.J., AlJumaili Z. Synchronous Diagnosis of Squamous Cell Carcinoma of the Lung and Mixed Cellularity Hodgkin Lymphoma of the Nasopharynx. Cureus. 2022; 14(12): e32885. doi: 10.7759/cureus.32885.</mixed-citation><mixed-citation xml:lang="en">Yohannan B., Sridhar A., Kachira J.J., AlJumaili Z. Synchronous Diagnosis of Squamous Cell Carcinoma of the Lung and Mixed Cellularity Hodgkin Lymphoma of the Nasopharynx. Cureus. 2022; 14(12): e32885. doi: 10.7759/cureus.32885.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fujii M., Shirai T., Asada K., Saito Y., Hirose M., Suda T. Synchronous diffuse large B-cell lymphoma and squamous cell lung carcinoma. Respirol Case Rep. 2014; 2(1): 33–35. doi: 10.1002/rcr2.40.</mixed-citation><mixed-citation xml:lang="en">Fujii M., Shirai T., Asada K., Saito Y., Hirose M., Suda T. Synchronous diffuse large B-cell lymphoma and squamous cell lung carcinoma. Respirol Case Rep. 2014; 2(1): 33–35. doi: 10.1002/rcr2.40.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Libshitz H.I., Zornoza J., McLarty J.W. Lung cancer in chronic leukemia and lymphoma. Radiology. 1978; 127(2): 297–300. doi: 10.1148/127.2.297.</mixed-citation><mixed-citation xml:lang="en">Libshitz H.I., Zornoza J., McLarty J.W. Lung cancer in chronic leukemia and lymphoma. Radiology. 1978; 127(2): 297–300. doi: 10.1148/127.2.297.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Videbaek A. Heredity in Human Leukemia and Its Relationship to Cancer. Copenhagen, Arnold Busch. 1947. pp 82–91.</mixed-citation><mixed-citation xml:lang="en">Videbaek A. Heredity in Human Leukemia and Its Relationship to Cancer. Copenhagen, Arnold Busch. 1947. pp 82–91.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Moertel C.G., Hagedorn A.B. Leukemia or lymphoma and coexistent primary malignant lesions: a review of the literature and a study of 120 cases. Blood. 1957; 12(9): 788–803.</mixed-citation><mixed-citation xml:lang="en">Moertel C.G., Hagedorn A.B. Leukemia or lymphoma and coexistent primary malignant lesions: a review of the literature and a study of 120 cases. Blood. 1957; 12(9): 788–803.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
